Literature DB >> 26201825

(18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.

M Beheshti1, F M Mottaghy2,3, F Paycha4, F F F Behrendt2, T Van den Wyngaert5, I Fogelman6, K Strobel7, M Celli8, S Fanti8, F Giammarile9, B Krause10, W Langsteger11.   

Abstract

The aim of this guideline is to provide minimum standards for the performance and interpretation of (18)F-NaF PET/CT scans. Standard acquisition and interpretation of nuclear imaging modalities will help to provide consistent data acquisition and numeric values between different platforms and institutes and to promote the use of PET/CT modality as an established diagnostic modality in routine clinical practice. This will also improve the value of scientific work and its contribution to evidence-based medicine.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26201825     DOI： 10.1007/s00259-015-3138-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


  83 in total

1.  Procedure guideline for bone scintigraphy: 1.0. Society of Nuclear Medicine.

Authors:  K J Donohoe; R E Henkin; H D Royal; M L Brown; B D Collier; R E O'Mara; R F Carretta
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

2.  The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.

Authors:  Ruoh-Fang Yen; Chih-Yu Chen; Mei-Fang Cheng; Yen-Wen Wu; Yu-Chien Shiau; Karl Wu; Ruey-Long Hong; Chong-Jen Yu; Kao-Lun Wang; Rong-Sen Yang
Journal:  Nucl Med Commun       Date:  2010-07       Impact factor: 1.690

3.  The single-passage extraction of 18F in rabbit bone.

Authors:  R Wootton; C Doré
Journal:  Clin Phys Physiol Meas       Date:  1986-11

4.  Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET.

Authors:  C Schiepers; J Nuyts; G Bormans; J Dequeker; R Bouillon; L Mortelmans; A Verbruggen; M De Roo
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

5.  Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.

Authors:  Bruce E Hillner; Barry A Siegel; Lucy Hanna; Fenghai Duan; Anthony F Shields; R Edward Coleman
Journal:  J Nucl Med       Date:  2014-02-27       Impact factor: 10.057

6.  F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.

Authors:  Martin Hetzel; Coskun Arslandemir; Hans-Helmut König; Andreas K Buck; Karin Nüssle; Gerhard Glatting; Andreas Gabelmann; Jürgen Hetzel; Vinzenz Hombach; Holger Schirrmeister
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

7.  Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Wolfgang Loidl; Gabriele Broinger; Franz Stoiber; Ignac Foglman; Werner Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

8.  Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.

Authors:  Bingsheng Huang; Martin Wai-Ming Law; Pek-Lan Khong
Journal:  Radiology       Date:  2009-02-27       Impact factor: 11.105

9.  Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients.

Authors:  H Palmedo; C Marx; A Ebert; B Kreft; Y Ko; A Türler; R Vorreuther; U Göhring; H H Schild; T Gerhardt; U Pöge; S Ezziddin; H-J Biersack; H Ahmadzadehfar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-24       Impact factor: 9.236

10.  High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis--a bone-enthesis-nail complex.

Authors:  Ai Lyn Tan; Steven F Tanner; Michael L Waller; Elizabeth M A Hensor; Alison Burns; Alan P Jeavons; Robert F Bury; Paul Emery; Dennis McGonagle
Journal:  Rheumatology (Oxford)       Date:  2013-01-09       Impact factor: 7.580
View more
  34 in total

1.  Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT.

Authors:  Wouter van der Bruggen; Marlous Hagelstein-Rotman; Lioe-Fee de Geus-Oei; Frits Smit; P D Sander Dijkstra; Natasha M Appelman-Dijkstra; Dennis Vriens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-24       Impact factor: 9.236

2.  Quantitative in vivo assessment of bone allograft viability using 18F-fluoride PET/CT after glenoid augmentation in reverse shoulder arthroplasty: a pilot study.

Authors:  Josef Hochreiter; Georg Mattiassich; Wolfgang Hitzl; Georg Weber; Mohsen Beheshti; Reinhold Ortmaier
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-06-06

3.  Kinetic [18F]-Fluoride of the Knee in Normal Volunteers.

Authors:  Bryan Haddock; Audrey P Fan; Niklas R Jørgensen; Charlotte Suetta; Garry Evan Gold; Feliks Kogan
Journal:  Clin Nucl Med       Date:  2019-05       Impact factor: 7.794

4.  Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.

Authors:  Jing Zhou; Zhengxing Gou; Renhui Wu; Yuan Yuan; Guiquan Yu; Yigang Zhao
Journal:  Skeletal Radiol       Date:  2019-05-24       Impact factor: 2.199

5.  Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.

Authors:  Paulo Schiavom Duarte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

Review 6.  Non-FDG PET/CT in Diagnostic Oncology: a pictorial review.

Authors:  Francesco Giammarile; Paolo Castellucci; Rudi Dierckx; Enrique Estrada Lobato; Mohsen Farsad; Roland Hustinx; Amirreza Jalilian; Olivier Pellet; Susana Rossi; Diana Paez
Journal:  Eur J Hybrid Imaging       Date:  2019-11-29

7.  Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma.

Authors:  Christos Sachpekidis; Jens Hillengass; Hartmut Goldschmidt; Hoda Anwar; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

8.  Initial experience with 18F-sodium fluoride (NaF) PET-CT: a viable functional biomarker in symptomatic Os acromiale.

Authors:  Sharjeel Usmani; Fahad Marafi; Abdulredha Esmail; Najeeb Ahmed
Journal:  Br J Radiol       Date:  2018-01-12       Impact factor: 3.039

9.  Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.

Authors:  Christos Sachpekidis; J Hillengass; H Goldschmidt; B Wagner; U Haberkorn; K Kopka; A Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-29       Impact factor: 9.236

Review 10.  Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors:  Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-09       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.